Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Sales and DivestituresNet Cash FlowNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

biote (BTMD) Change in Accured Expenses: 2021-2024

Historic Change in Accured Expenses for biote (BTMD) over the last 4 years, with FY2024 value amounting to $4.6 million.

  • biote's Change in Accured Expenses rose 6513.2% to $2.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$4.1 million, marking a year-over-year decrease of 25840.55%. This contributed to the annual value of $4.6 million for FY2024, which is 10836.71% up from last year.
  • Per biote's latest filing, its Change in Accured Expenses stood at $4.6 million for FY2024, which was up 10836.71% from $2.2 million recorded in FY2023.
  • In the past 5 years, biote's Change in Accured Expenses ranged from a high of $4.6 million in FY2024 and a low of -$30.8 million during FY2022
  • Over the past 4 years, biote's median Change in Accured Expenses value was $3.1 million (recorded in 2021), while the average stood at -$5.0 million.
  • In the last 5 years, biote's Change in Accured Expenses plummeted by 86547.53% in 2022 and then surged by 10836.71% in 2024.
  • Annual analysis of 4 years shows biote's Change in Accured Expenses stood at $4.0 million in 2021, then tumbled by 865.48% to -$30.8 million in 2022, then surged by 107.21% to $2.2 million in 2023, then soared by 108.37% to $4.6 million in 2024.
  • Its Change in Accured Expenses was $4.6 million in FY2024, compared to $2.2 million in FY2023 and -$30.8 million in FY2022.